STOCK TITAN

[Form 4] Thermo Fisher Scientific, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Gianluca Pettiti, listed as Executive Vice President of Thermo Fisher Scientific (TMO), reported multiple dispositions of Common Stock on 08/28/2025. Four separate line items show sales (transaction code F) totaling 814.702 shares at $489.74 per share, with post-transaction beneficial ownership reported as 21,552.223 to 22,167.238 shares across the entries. The Form 4 is signed by an attorney-in-fact on 09/02/2025. The filing provides name, address, role, transaction dates, codes, quantities, price, and resulting ownership figures.

Gianluca Pettiti, indicato come Executive Vice President di Thermo Fisher Scientific (TMO), ha dichiarato multiple disposizioni di azioni ordinarie in data 28/08/2025. Quattro voci separate mostrano vendite (codice transazione F) per un totale di 814.702 azioni a $489.74 ciascuna, con la titolarità post-transazione riportata come 21,552.223 a 22,167.238 azioni nelle diverse registrazioni. Il Modulo 4 è firmato da un procuratore in data 02/09/2025. Il deposito fornisce nome, indirizzo, ruolo, date e codici delle transazioni, quantità, prezzo e dati sulla proprietà risultante.

Gianluca Pettiti, registrado como Executive Vice President de Thermo Fisher Scientific (TMO), informó múltiples disposiciones de acciones comunes el 28/08/2025. Cuatro asientos separados muestran ventas (código de transacción F) por un total de 814.702 acciones a $489.74 por acción, con la propiedad posterior a la transacción reportada como 21,552.223 a 22,167.238 acciones en las distintas entradas. El Formulario 4 está firmado por un apoderado el 02/09/2025. La presentación incluye nombre, dirección, cargo, fechas y códigos de las transacciones, cantidades, precio y cifras de propiedad resultante.

Gianluca Pettiti, Thermo Fisher Scientific(TMO)의 Executive Vice President로 등재된 인물은 2025-08-28에 여러 보통주 처분을 보고했습니다. 네 건의 별도 항목에는 매도(거래 코드 F)가 총 814.702주에 대해 주당 $489.74로 기재되어 있으며, 거래 후 소유 주식 수는 항목별로 21,552.223에서 22,167.238주로 보고되었습니다. Form 4는 대리인이 2025-09-02에 서명했습니다. 제출서에는 이름, 주소, 직책, 거래일자와 코드, 수량, 가격 및 결과 소유 지분 수치가 포함되어 있습니다.

Gianluca Pettiti, indiqué comme Executive Vice President de Thermo Fisher Scientific (TMO), a déclaré plusieurs cessions d'actions ordinaires le 28/08/2025. Quatre lignes distinctes montrent des ventes (code de transaction F) totalisant 814.702 actions à $489.74 par action, avec une propriété post-transaction reportée entre 21,552.223 et 22,167.238 actions selon les entrées. Le formulaire 4 est signé par un mandataire le 02/09/2025. le dépôt fournit le nom, l'adresse, le rôle, les dates et codes des transactions, les quantités, le prix et les chiffres de propriété résultants.

Gianluca Pettiti, aufgeführt als Executive Vice President von Thermo Fisher Scientific (TMO), meldete mehrere Veräußerungen von Stammaktien am 28.08.2025. Vier separate Einträge zeigen Verkäufe (Transaktionscode F) in Höhe von insgesamt 814.702 Aktien zu je $489.74, wobei das nach der Transaktion gehaltene Aktienvolumen in den Einträgen mit 21,552.223 bis 22,167.238 Aktien angegeben ist. Das Formular 4 wurde am 02.09.2025 von einem Bevollmächtigten unterschrieben. Die Einreichung enthält Name, Adresse, Funktion, Transaktionsdaten und -codes, Mengen, Preis und die resultierenden Besitzangaben.

Positive
  • None.
Negative
  • Insider disposals reported: Four sales totaling 814.702 shares at $489.74 per share on 08/28/2025 (transaction code F).
  • Reduction in holdings: Post-transaction beneficial ownership figures are reported between 21,552.223 and 22,167.238 shares.

Insights

TL;DR: Insider sold 814.702 shares at $489.74 on 08/28/2025; post-sale holdings remain ~21.6K–22.2K shares.

The Form 4 documents four disposals by Executive Vice President Gianluca Pettiti using transaction code F on 08/28/2025. The aggregate disposed amount reported across the entries is 814.702 shares at $489.74 each. The filing shows the resulting beneficial ownership per line between 21,552.223 and 22,167.238 shares. This is a routine disclosure of insider selling activity; no derivative transactions or other material changes are reported.

TL;DR: Proper Section 16 disclosure filed; sale reported via Form 4 and signed by attorney-in-fact.

The document identifies the reporting person, role (Executive Vice President), issuer (Thermo Fisher Scientific, TMO), and specifies transaction code F for four disposals on 08/28/2025. The form includes post-transaction beneficial ownership figures and a signature by an attorney-in-fact dated 09/02/2025, indicating procedural compliance with Section 16 reporting requirements. No amendments or additional context are provided.

Gianluca Pettiti, indicato come Executive Vice President di Thermo Fisher Scientific (TMO), ha dichiarato multiple disposizioni di azioni ordinarie in data 28/08/2025. Quattro voci separate mostrano vendite (codice transazione F) per un totale di 814.702 azioni a $489.74 ciascuna, con la titolarità post-transazione riportata come 21,552.223 a 22,167.238 azioni nelle diverse registrazioni. Il Modulo 4 è firmato da un procuratore in data 02/09/2025. Il deposito fornisce nome, indirizzo, ruolo, date e codici delle transazioni, quantità, prezzo e dati sulla proprietà risultante.

Gianluca Pettiti, registrado como Executive Vice President de Thermo Fisher Scientific (TMO), informó múltiples disposiciones de acciones comunes el 28/08/2025. Cuatro asientos separados muestran ventas (código de transacción F) por un total de 814.702 acciones a $489.74 por acción, con la propiedad posterior a la transacción reportada como 21,552.223 a 22,167.238 acciones en las distintas entradas. El Formulario 4 está firmado por un apoderado el 02/09/2025. La presentación incluye nombre, dirección, cargo, fechas y códigos de las transacciones, cantidades, precio y cifras de propiedad resultante.

Gianluca Pettiti, Thermo Fisher Scientific(TMO)의 Executive Vice President로 등재된 인물은 2025-08-28에 여러 보통주 처분을 보고했습니다. 네 건의 별도 항목에는 매도(거래 코드 F)가 총 814.702주에 대해 주당 $489.74로 기재되어 있으며, 거래 후 소유 주식 수는 항목별로 21,552.223에서 22,167.238주로 보고되었습니다. Form 4는 대리인이 2025-09-02에 서명했습니다. 제출서에는 이름, 주소, 직책, 거래일자와 코드, 수량, 가격 및 결과 소유 지분 수치가 포함되어 있습니다.

Gianluca Pettiti, indiqué comme Executive Vice President de Thermo Fisher Scientific (TMO), a déclaré plusieurs cessions d'actions ordinaires le 28/08/2025. Quatre lignes distinctes montrent des ventes (code de transaction F) totalisant 814.702 actions à $489.74 par action, avec une propriété post-transaction reportée entre 21,552.223 et 22,167.238 actions selon les entrées. Le formulaire 4 est signé par un mandataire le 02/09/2025. le dépôt fournit le nom, l'adresse, le rôle, les dates et codes des transactions, les quantités, le prix et les chiffres de propriété résultants.

Gianluca Pettiti, aufgeführt als Executive Vice President von Thermo Fisher Scientific (TMO), meldete mehrere Veräußerungen von Stammaktien am 28.08.2025. Vier separate Einträge zeigen Verkäufe (Transaktionscode F) in Höhe von insgesamt 814.702 Aktien zu je $489.74, wobei das nach der Transaktion gehaltene Aktienvolumen in den Einträgen mit 21,552.223 bis 22,167.238 Aktien angegeben ist. Das Formular 4 wurde am 02.09.2025 von einem Bevollmächtigten unterschrieben. Die Einreichung enthält Name, Adresse, Funktion, Transaktionsdaten und -codes, Mengen, Preis und die resultierenden Besitzangaben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pettiti Gianluca

(Last) (First) (Middle)
168 THIRD AVENUE

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/28/2025 F 199.687 D $489.74 22,167.238 D
Common Stock 08/28/2025 F 212.258 D $489.74 21,954.98 D
Common Stock 08/28/2025 F 253.354 D $489.74 21,701.626 D
Common Stock 08/28/2025 F 149.403 D $489.74 21,552.223 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Melodie T. Morin, Attorney-in-Fact for Gianluca Pettiti 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Thermo Fisher Scientific (TMO)?

The reporting person is Gianluca Pettiti, listed as Executive Vice President, with address provided in the filing.

What transactions are reported on this Form 4 for TMO?

Four dispositions (transaction code F) of Common Stock on 08/28/2025, totaling 814.702 shares at $489.74 per share.

What were Gianluca Pettiti's reported holdings after the transactions?

The filing shows post-transaction beneficial ownership amounts between 21,552.223 and 22,167.238 shares across the reported lines.

Was the Form 4 signed and when?

Yes. The form is signed by Melodie T. Morin, Attorney-in-Fact for Gianluca Pettiti dated 09/02/2025.

Does the filing report any derivative transactions?

No. Table II for derivative securities contains no entries in this filing.
Thermo Fishr Sci

NYSE:TMO

TMO Rankings

TMO Latest News

TMO Latest SEC Filings

TMO Stock Data

186.06B
376.94M
0.16%
91.85%
0.98%
Diagnostics & Research
Measuring & Controlling Devices, Nec
Link
United States
WALTHAM